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Although tobacco appears highly addictive in humans, there has been persistent controversy about the ability of its
psychoactive ingredient nicotine to induce self-administration behavior in laboratory animals, bringing into question
nicotine’s role in reinforcing tobacco smoking. Because of ethical difficulties in inducing nicotine dependence in naı ¨ve human
subjects, we explored reinforcing effects of nicotine in experimentally-naive non-human primates given access to nicotine for
periods of time up to two years. Five squirrel monkeys with no experimental history were allowed to intravenously self-
administer nicotine by pressing one of two levers. The number of presses on the active lever needed to obtain each injection
was fixed (fixed-ratio schedule) or increased progressively with successive injections during the session (progressive-ratio
schedule), allowing evaluation of both reinforcing and motivational effects of nicotine under conditions of increasing response
cost. Over time, a progressive shift toward high rates of responding on the active lever, but not the inactive lever, developed.
The monkeys’ behavior was clearly directed toward nicotine self-administration, rather than presentation of environmental
stimuli associated with nicotine injection. Both schedules of reinforcement revealed a high motivation to self-administer
nicotine, with monkeys continuing to press the lever when up to 600 lever-presses were needed for each injection of nicotine.
Thus, nicotine, by itself, in the absence of behavioral or drug-exposure history, is a robust and highly effective reinforcer of
drug-taking behavior in a non-human primate model predictive of human behavior. This supports the use of nicotinic ligands
for the treatment of smokers, and this novel preclinical model offers opportunities to test future medications for the treatment
of nicotine dependence.
Citation: Le Foll B, Wertheim C, Goldberg SR (2007) High Reinforcing Efficacy of Nicotine in Non-Human Primates. PLoS ONE 2(2): e230. doi:10.1371/
journal.pone.0000230
INTRODUCTION
Tobacco dependence is described as a chronic, relapsing disorder in
which compulsive drug-seeking and drug-taking behavior persists
despite negative consequences and the motivation to quit. The
highly addictive properties of tobacco are exemplified by the great
difficultyinquittingsmoking.Althoughmostsmokersexpressadesire
to stop smoking, only a small percentage of subjects succeed [1,2].
Surprisingly, reinforcing effects of nicotine alone have often been
difficult to demonstrate directly in controlled laboratory studies with
both animals and humans as experimental subjects. Consequently,
there has been continuing controversy in the literature about the
validity of previous findings of reinforcing effects of nicotine in
experimental animals and human subjects [3,4,5,6,7,8].
The first attempts to demonstrate nicotine self-administration in
drug-naiveanimalswereperformedinnon-humanprimates.Table1
provides an overview of the published studies performed with the
nicotine self-administration paradigm in non-human primates. Most
of these studies do not support the conclusion that nicotine can
function as an effective reinforcing agent. Without specific condi-
tions, such as automatic nicotine infusions, previous self-administra-
tion of other drugs or food, or food-deprivation, nicotine previously
failed to maintain significant self-administration behavior in non-
human primates (Table 1). These findings are in striking contrast to
the vast literature that indicates that other drugs of abuse such as
cocaine or opiates can initiate and maintain self-administration
behavior in non-human primates. However, these studies with
nicotine self-administration in non-human primates used experi-
mental conditions, such as very slow injection duration or pre-
training on cocaine, that may not have been adequate.
The experimental conditions used may strongly influence the
outcome of drug self-administration studies in rodents. Indeed,
without adequate conditions, the initial explorations performed in
rats suggested that nicotine did not possess any reinforcing
properties [5]. Although, some investigators have been able to
obtain significant intravenous self-administration behavior with
nicotine in rats [9], the findings of these studies have often not
been reproduced [10] and the conclusions have been critized due
to the fact that most studies employed conditions such as priming
injections of nicotine before sessions, food deprivation or previous
food self-administration training, that may have resulted in non-
specific responding [5]. The difficulty in obtaining significant self-
administration suggests that the reinforcing effects of nicotine are
weak in rodents. This hypothesis is supported by the limited
efficacy of nicotine to induce significant conditioned place
preferences (see [11] for a review) and is in opposition to the
apparent high reinforcing effects of tobacco in human smokers.
This discrepancy between the apparent high reinforcing effects
of tobacco in humans and the apparent weak reinforcing effects of
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most recent ones being that nicotine may produce its reinforcing
effects indirectly through its conditioning properties [12] or that
other substances contained in tobacco smoke may be necessary for
the reinforcing effects of tobacco [10,13].
The critical role environmental stimuli play in the maintenance
of intravenous nicotine self-administration behavior was initially
proposed following the description of the ability of nicotine to
maintain responding under a second-order schedule of intrave-
nous nicotine self-administration in squirrel monkeys [14]. With
this schedule of reinforcement, responding is maintained to a large
extent by the brief light stimuli which are only intermittently
paired with nicotine delivery. This hypothesis is supported by
recent rodent experiments. In these experiments, light stimuli were
paired with each self-administered injection of nicotine. In one
study with rats, discontinuing presentation of the environmental
stimuli paired with intravenous nicotine injection decreased self-
administration behavior almost as effectively as the removal of
nicotine itself [12,15,16]. In another recent study with rats,
response-contingent presentation of stimuli previously paired with
nicotine injections, by themselves, continued to maintain levels of
responding equal to those previously maintained by injections of
nicotine for up to three months, demonstrating the persistent
nature and high motivational value of these environmental stimuli
[17].
One theory that has been recently proposed to explain the
difficulties involved in obtaining nicotine self-administration is that
substances other than nicotine in tobacco smoke possess psycho-
active effects and contribute to the reinforcing effects of tobacco
smoking [18]. Among the likely candidates are substances present
in tobacco smoke that are able to inhibit monoamine-oxidase
(MAO) enzymes, which are inhibited in the brain of smokers
[19,20]. Recent results obtained in rats suggest that treatment with
MAO inhibitors may potentiate the reinforcing effects of in-
travenously self-administered nicotine [21]. However, conflicting
results have been obtained in mice [22] and the results obtained in
rats were obtained with a degree of MAO inhibition that is much
higher than that observed in the brains of smokers.
Another possibility that may explain the discrepancy between
the apparent high reinforcing effects of tobacco in humans and the
apparent weak reinforcing effects of nicotine in rodents is that
nicotine may possess higher reinforcing effects in primates than in
rodents and that these reinforcing effects have not been revealed
by previous investigations in primates due to inappropriate
conditions. Here we explored this hypothesis by evaluating the
direct reinforcing effects of nicotine in experimentally-naive
squirrel monkeys using a fixed-ratio (FR) schedule of reinforce-
ment. The squirrel monkeys studied were experimentally naive at
the beginning of the study: they had no history of exposure to
drugs other than anesthetics used for surgery and antibiotics, no
history of drug self-administration and had not been trained to
respond for food. Due to the growing literature obtained in
rodents suggesting that nicotine may act by increasing the
motivational value of environmental stimuli associated with its
effects, brief light stimuli were associated with each completion of
the FR response requirement on both active and inactive levers.
Responding for various doses of nicotine was evaluated and dose-
response curves generated once the monkeys learned to quickly
reduce their responding when saline was substituted for nicotine.
Nicotine self-administration responding of the monkeys was also
evaluated under a progressive-ratio (PR) schedule of reinforcement
which provided a motivational measure of the amount of effort
monkeys would exert to obtain an intravenous injection of
nicotine.
RESULTS
Acquisition of nicotine self-administration behavior
All the monkeys studied acquired nicotine self-administration
under the FR schedule of reinforcement. The monkeys were
initially allowed to self-administer 10 mg/kg nicotine injections
under a FR 1 schedule of reinforcement and, over subsequent
sessions, the response requirement was gradually increased to FR
10. It took 25 to 101 sessions (mean 70617 sessions) for monkeys
to reach the final FR 10, time-out (TO) 60 sec schedule. During
the first week of acquisition, no preference was noted for the active
versus the inactive lever (percentage choice on the active lever was
49.669.3%, as expected by chance) (Fig. 1B). This indicates that
during these initial sessions, the animals produced a similar
number of two-sec light presentations by responding on the active
and the inactive levers. However, over repeated sessions the
monkeys developed a strong preference for responding on the
active-lever compared to the inactive-lever (P,0.01) and respond-
ing on the inactive-lever dropped to negligeable levels (Fig. 1B).
Table 1. Summary of previous studies evaluating intravenous nicotine self-administration behavior in non-human primates.
..................................................................................................................................................
Species Schedule
Previous training and exposure to experimenter administered
non-contingent nicotine injections Nicotine self-administration Ref
Rhesus FR Absence of automatic nicotine injections No [57]
Presence of automatic nicotine injections Yes
Rhesus FR or PR History of self-administering other drugs No [58]
Baboons FR Food or cocaine self-administration history No [39]
Squirrel Second-order Priming injection and cocaine self-administration history Yes [14]
Squirrel Fixed-interval Automatic injections or cocaine self-administration history Yes [41]
Baboons FR Drug self-administration history (for 3 out of 4 monkeys) No [40]
Rhesus FR Food-restriction and previous operant training No [59]
Rhesus FR Cocaine self-administration history No [60]
Squirrel FR Cocaine self-administration history Yes [61]
Rhesus FR Drug self-administration history Yes [42]
doi:10.1371/journal.pone.0000230.t001
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The first time saline was substituted for nicotine under the FR 10
schedule, responding on the active lever continued undiminished,
suggesting that the nicotine-associated brief light stimuli previously
associated with nicotine injection, were as effective as nicotine itself
in maintaining self-administration responding. Analysis of the
number of injections per session over six consecutive sessions,
three with nicotine injections followed by three with saline
substituted for nicotine, revealed that substitution of saline for
nicotine initially had no effect on responding (F4,20=0.22,
P=0.9, Fig 2).
After acquisition of stable nicotine self-administration behavior
under the FR 10, TO 60 sec schedule, the monkeys again had
saline substituted for nicotine over repeated sessions. Responding
of three of the monkeys extinguished after 5 to 17 sessions of saline
substitution. Two monkeys did not initially show extinction of
responding under the FR 10 schedule and were switched to the
progressive-ratio schedule. These two monkeys showed extinction
of responding after 7 or 13 sessions of responding for saline under
the progressive-ratio schedule and were then returned to the FR
10 schedule. After this history, the number of injections self-
administered per session immediately decreased to low levels when
saline injections were again substituted for 10 mg/kg nicotine
injections under the FR 10 schedule and self-administration
responding immediately returned to high levels when saline
injections were replaced with 10 mg/kg nicotine injections (Fig. 3).
Repeated measures ANOVA indicated a significant effect of lever
(F1,64=19.9, P=0.002), a significant effect of time (F8,64=7.4,
P,0.0001), and a significant time x lever interaction (F8,64=7.4,
P,0.0001). Post-hoc analysis indicated that the number of ratios
completed on the active lever were significantly lower during saline
substitution compared to nicotine acess conditions (all P,0.001).
In contrast, no significant changes were noted in the number of
ratios completed on the inactive lever (all P.0.95). Under the final
FR 10 TO 60 sec schedule, injections of 10 mg/kg nicotine
maintained relatively high response rates (0.1560.04 response/s
compared to 0.0160.001 response/s for saline. P,0.01) and
about 50% of the maximal possible number of injections per
session was self-administered each session (2764 injections/1-hour
session) (Fig. 4A).
Nicotine dose variations under the fixed-ratio
schedule
Varying the nicotine dose per injection resulted in an inverted U-
shaped dose-effect curve, similar to curves typically obtained with
other abused drugs under FR schedules of intravenous drug self-
administration (Fig 4A). Two-way analysis ANOVA indicated that
there was a significant effect of lever choice (active vs inactive,
F1,32=46.5, P,0.0001), a significant effect of nicotine dose
Figure 1. A. Monkeys sat in chambers equipped with two levers and distinctly colored light stimuli above the levers. Completion of the response
requirement (the ratio) on the active lever produced a brief two-sec presentation of a light stimulus and an intravenous injection of nicotine followed
by a timeout (TO) period of 5 to 60 sec. Completion of the ratio requirement on the inactive lever resulted in presentation of a brief two-sec light
stimulus of a different color but no injection. The fixed-ratio (FR) response requirement was gradually increased over successive sessions from one to
ten (FR 1 to FR 10). B. Mean percentage choice for responding on the active lever by monkeys when they were experimentally naive (first week under
a FR 1 schedule) and when they had learned to self-administer nicotine under the FR 10, TO 60 sec schedule (first week under the FR 10 schedule).
*P,0.01, compared to first week of training.
doi:10.1371/journal.pone.0000230.g001
Figure 2. Maintenance of self-administration behavior under the FR 10
schedule during the first experience with saline substitution. Mean
number (6SEM) of ratios completed on the active lever during three
consecutive session with access to nicotine followed by an additional
three sessions with saline substituted for nicotine are shown. The brief
2-sec light stimuli were presented following each ratio completion
during both the nicotine and saline sessions. Self-administration
behavior was not reduced by the substitution of saline injections for
nicotine injections during this first exposure to extinction conditions.
doi:10.1371/journal.pone.0000230.g002
Non-Human Primate and Nicotine
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choice and nicotine dose (F3,32=5.4, P=0.004). Post-hoc analysis
indicated that all nicotine doses maintained high rates of respond-
ing on the active lever compared to saline substitution conditions
(P=0.002, P,0.0001 and P=0.04 for nicotine 3, 10, 30 mg/kg
per injection, respectively). There was no effect of nicotine dose on
responding on the inactive lever (all P.0.4). There was
a significant effect of nicotine dose on total nicotine intake during
the 1-hour session (F3,16=40.4, P,0.0001) (Fig. 4B). Post-hoc
analysis indicated that total nicotine intake significantly increased
when the monkey had access to 10 mg/kg and 30 mg/kg nicotine
injections (all P,0.0001 compared to saline acess conditions).
Patterns of responding by the monkeys were typical of FR
responding maintained by other drugs of abuse: when the green
light was illuminated, an initial pause in responding was followed
by an abrupt change to rapid responding that continued until the
ratio was comleted. Rates of responding were very low during
saline substitution and were highest at the peak dose of 10 mg/kg
per injection of nicotine.
Nicotine self administration under the progressive-
ratio schedule
Under the progressive-ratio schedule, responding seldom occurred
on the inactive lever and almost all ratios completed by the
monkeys were on the active lever, in agreement with the strong
preference for the active lever that had developed over time under
the FR schedules (see above). There was a significant effect of
nicotine dose on total number of injections during the session
(F4,20=6.9, P=0.001) and on total nicotine intake (F4,20=10.8,
P,0.0001). Post-hoc analysis indicated that all nicotine doses
maintained high rates of responding on the active lever compared
to rates of responding during saline substitution (P=0.03,
Figure 3. Maintenance, extinction and reacquisition of self-administra-
tion behavior over consecutive sessions under the FR 10 schedule of
reinforcement. Numbers of injections per session during consecutive
nicotine (10 mg/kg per injection, filled symbols) and saline self-
administration sessions (open symbols) are presented. Symbols
represent the mean (6SEM) number of ratios completed on the active
(circle) or inactive (triangle) levers per session from five squirrel
monkeys. *P,0.05, compared to nicotine sessions.
doi:10.1371/journal.pone.0000230.g003
Figure 4 Influence of nicotine dose on nicotine self-administration and
total nicotine intake per session under the FR 10 schedule. Number of
fixed ratios completed on the active and inactive levers per session (A)
and total nicotine intake per session (B) are presented as a function of
injection dose of nicotine (n=5). Each symbol represents the mean
(6SEM) of at least three sessions under each nicotine injection dose
condition *P,0.05, **P,0.01 post-hoc comparisons with the saline
vehicle (0 mg/kg per injection) conditions.
doi:10.1371/journal.pone.0000230.g004
Non-Human Primate and Nicotine
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per injection, respectively) . Again, there was an inverted U-shaped
dose-effect curve, with the 30 mg/kg per injection dose of nicotine
maintaining peak values for number of injections per session and
breaking point (Fig. 5A) and a near maximal nicotine intake per
session (Fig. 5B). When nicotine dose was further increased to
60 mg/kg per injection, the number of injections per session and
breaking point values decreased (Fig. 5A) and there was no further
increase in nicotine intake per session (Fig. 5B). Under the
progressive-ratio schedule, monkeys continued to press the lever
when up to 600 lever-presses were needed for a single nicotine
injection, clearly demonstrating a high motivation to self-
administer nicotine (Fig. 5A).
DISCUSSION
The present findings provide a clear demonstration of nicotine’s
effectiveness as a reinforcer of drug-taking behavior in experi-
mentally naive non-human primates. In the present experiments,
nicotine initiated and sustained very high rates of intravenous self-
administration behavior in squirrel monkeys without a history of
exposure to other drugs or behavioral training and without any
facilitory conditions, such as food-deprivation or non-contingent
automatic injections of nicotine before or during experimental
sessions. There was a high motivation to obtain nicotine under
both the FR and the progressive-ratio schedules. Under the FR
schedule, about 50% of the maximal possible number of injections
per session was self-administered each session and, under the
progressive-ratio schedule, monkeys continued to press the lever at
a high rate when up to 600 lever-presses were needed for each
injection of nicotine.
Under the present FR schedule of intravenous drug self-
administration, the pattern of responding maintained by nicotine
was similar to patterns of responding maintained by intravenous
injections of cocaine, d-amphetamine, methohexital or delta-9-
tetrahydrocannabinol (THC) in previous studies using the same
primate species and similar FR schedules of intravenous drug
injection [23,24,25,26] although the present peak rate of
responding with nicotine was less intense than peak rates of
responding previously reported with other drugs of abuse such as
cocaine, d-amphetamine and THC. This is in agreement with
results from a previous study with rats, which directly compared,
in the same animals, the reinforcing effects of nicotine with those
of cocaine under a progressive-ratio schedule and found that the
reinforcing effects of nicotine were weaker than those of cocaine
[27] and that animals prefered cocaine over nicotine, when given
access to both drugs during the same session [27].
This is the first report of clear reinforcing effects of nicotine in
non-human primates using the progressive-ratio schedule of
reinforcement and the first reported use of this schedule of
reinforcement with squirrel monkeys. Breaking-point values were
relatively high in the squirrel monkeys (around 600 lever press to
get a single nicotine injection), suggesting that nicotine possesses
high motivational effects in primates. It is interesting that the
present levels of responding maintained by intravenous nicotine in
squirrel monkeys are relatively close to levels of responding
recently reported in human smokers self-administering nicotine
intravenously [28]. In the human study, when the number of
responses required for each injection was progressively increased
over consecutive sessions, high rates of responding were main-
tained by nicotine injections, but not by concurrently available
saline injections, at response requirements as high as 1600
responses per injection. Mean rates of responding were between
2.3 and 3.3 responses per second for nicotine injections at maximal
FR values ranging from 400 to 1600 in individual subjects,
compared to under 0.3 responses per second for concurrently
available saline placebo injections [28]. In contrast to the present
findings with squirrel monkeys and and our previous findings with
human subjects, levels of responding obtained with rodents in
nicotine self-administration studies have been significantly less
intense under progressive-ratio schedules, with breaking-points
values between 25 and 100 depending on the dose of nicotine used
and the investigators [29,30,31,32,33]. Also, the number of
nicotine injections per session is generally much lower in rats
compared to squirrel monkeys or humans, with the average
number of injections per session ranging between 6 to 10 injections
per session in most studies [29,30,31,32,33].
Figure 5. Influence of nicotine dose on nicotine self-administration and
total nicotine intake per session under the progressive-ratio schedule.
Number of nicotine injections per session and corresponding breaking-
point values (highest ratio completed) under the progressive-ratio
schedule (A) and total nicotine intake per session (B) are presented as
a function of injection dose of nicotine (n=5). Each symbol represents
the mean (6SEM) of at least three sessions under each nicotine
injection dose condition *P,0.05, **P,0.01 post-hoc comparisons with
saline vehicle (0 mg/kg per injection) conditions.
doi:10.1371/journal.pone.0000230.g005
Non-Human Primate and Nicotine
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paired with each nicotine injection during acquisition of the self-
administration behavior. This appeared to contribute to the ability
of nicotine to act as a reinforcer, in agreement with several recent
rodent experiments. The finding that self-administration respond-
ing continued to be maintained at high rates during the first
exposure to saline substitution conditions (Fig. 2) suggests that
habitual behavior had progressively developed in the monkeys and
that they were becoming insensitive to the outcome of their
actions. Another likely hypothesis, however, is that self-adminis-
tration behavior during the initial saline substitution sessions was
maintained by light stimuli that had been previously associated
with nicotine injections and continued to be presented in
association with saline injections [17,34].
Nicotine, like other psychostimulant drugs [35], also produces
unconditioned effects, unrelated to reinforcement, that can
increase the efectiveness of non-drug environmental stimuli as
reinforcers and this process can occur independently of any direct
temporal association between nicotine administration and stimulus
presentation [15,36,37]. In our experiments, however, during the
first week of acquisition of nicotine self-administration behavior,
the monkeys had similar exposure to brief light stimuli associated
with responding on both the active and inactive levers, since
responding on both levers was identical (Fig 1), but there was
a progressive shift in subsequent weeks toward responding on the
active lever. This progressive shift towards increased responding
on the active lever and reduced responding on the inactive lever,
which occurred even though responding on the inactive lever
continued to produce brief light stimuli, suggests that responding
of experienced animals was directed more toward delivery of
nicotine than toward presentation of the associated brief light
stimuli. It is also important to note that there was nicotine
exposure throughout each session as a result of responding on the
active lever and that exposure to nicotine alone did not result in the
brief light presentations produced by responding on the inactive
lever acquiring reinforcing efficacy. Finally, after repeated exposure
to cycles of saline substitution, substitution of saline for nicotine did
result in decreases in self-administration responding. Thus, in these
experienced monkeys, nicotine-associated stimuli, by themselves,
appeared unable to maintain significant self-administration behavior
under fixed- and progressive-ratio schedules.
The present findings contrast with the previous difficulties in
obtaining significant nicotine self-administration in non-human
primates (Table 1) and rodents. Several factors may explain such
discrepancies. An analysis of the speed of injection used in the
previous studies suggests that a rapid speed of nicotine injection,
which mimic kinetics of nicotine delivery with tobacco smoking
[38] may have been critical. Previous studies that used very slow
(2-min) injections of nicotine [39] or slow (5 sec or more) injections
of nicotine [40] did not provide significant evidence for reinforcing
effects of nicotine, whereas, nicotine had significant reinforcing
effects when injection durations of less than one sec were used
[14,41]. The importance of injection speed is also supported by
findings from one study that directly measured rates of nicotine
self-administration at different injection durations [42]. However,
injection speed cannot explain the lower reinforcing effects of
nicotine in rodents, since most of the rodent studies employed
relatively high infusion speeds.
Rodent self-administration studies generally last a maximum of
three to four months, due to catheter loss. In contrast, our monkey
self-administration studies extended over periods of one to two
years and this may have allowed time for monkeys to become
tolerant to some aversive effects of nicotine, thus revealing
nicotine’s high reinforcing effects. It has long been known that
nicotine can produce both reinforcing and aversive effects,
sometimes at the same dose, depending on the experimental
schedule under which nicotine is made available and the subject’s
history [43,44]. Humans report both positive and negative effects
following nicotine injections [28,45,46,47]. In agreement, the
same dose of nicotine may produce either positive or aversive
motivational effects in rats using conditioned place preference
procedures [11,48] and in squirrel monkeys using self-administra-
tion and punishment procedures [14,18,44]. Although we cannot
directly evaluate this hypothesis, it is possible that prolonged
exposure to nicotine over many months may have allowed the
monkeys to develop tolerance to some aversive effects of nicotine
and, therefore allowed the high reinforcing effects of nicotine to
develop.
Finally, the monkeysinthis study hadnopreviousexperiencewith
self-administration of other psychoactive drugs with different
pharmacological effects (e.g. cocaine), that may have influenced
effects of nicotine in earlier studies using non-human primates [49].
Exposure to one class of drugs may alter the subsequent effects of
drugs from another pharmacological class [49,50,51]. For example,
aversive effects of high doses of THC are revealed in nicotine-
experienced rats [51] and lower rates of intravenous THC self-
administration are described in monkeys with a history of cocaine
self-administration [25] compared to drug-naive monkeys [26].
In conclusion, these findings provide a clear demonstration that
nicotine, by itself, in the absence of a behavioral-testing or drug-
exposure history or existing conditions, such as food deprivation or
experimenter-administered nicotine injections, is a robust and
highly effective reinforcer of drug-taking behavior in a non-human
primate model predictive of human behavior. The monkeys’
behavior was clearly directed toward self-administration of
nicotine, rather than presentation of environmental stimuli
associated with nicotine’s effects. The experiments conducted in
monkeys without an extinction history also confirm the critical
influence of nicotine associated-stimuli in sustaining self-adminis-
tration behavior. Nicotine-seeking was persistent and robust, even
in the face of increases in response cost per nicotine dose (price) by
a factor of sixty. These findings support the use of nicotinic ligands
for the treatment of tobacco dependence. Moreover, the self-
administration of nicotine by squirrel monkeys provides a reliable
animal model of nicotine dependence, suitable for developing new
therapeutic strategies for the treatment or tobacco smoking in
humans. This model can be used to validate the use of novel
therapeutic approaches such as dopamine D3 ligands [52,53] or
cannabinoid CB1 ligands [54,55].
MATERIAL AND METHODS
Subjects
Five naive male squirrel monkeys (Saimiri sciurea), weighing 730
to 950 g were subjects. They were housed individually in
a temperature- and humidity-controlled room and were main-
tained on a 12-h light/dark cycle; the lights were on from 6:45 AM
to 6:45 PM. Experiments were conducted during the light phase.
Animals were maintained in facilities fully accredited by the
American Association for the Accreditation of Laboratory Animals
used in this study were maintained in facilities fully accredited by
the American Association for the Accreditation of Laboratory
Animal Care (AAALAC) and all experimentation was conducted
in accordance with the guidelines of the Institutional Care and Use
Committee of the Intramural Research Program, National
Institute on Drug Abuse, National Institutes of Health, and the
Guide for Care and Use of Laboratory Animals (National
Research Council 2003). In each monkey, a polyvinyl chloride
Non-Human Primate and Nicotine
PLoS ONE | www.plosone.org 6 February 2007 | Issue 2 | e230catheter (inside diameter, 0.38 mm; outside diameter 0.76 mm)
was used for i.v. injection of drug and was passed through the right
or left jugular vein or through the femoral vein to the level of the
right atrium under halothane anesthesia. Subcutaneous catheters
led to the monkey’s back where they exited the skin. The monkeys
wore jackets at all times to protect these catheters. Each weekday
the catheters were flushed, refilled with saline (0.9% NaC1) and
sealed with stainless steel obturators. Before acquisition of nicotine
self-administration, the monkeys have been euthanized to
performed brain imaging experiment using positron emission
tomography to measure the expression of brain nicotinic receptors.
These results will be reported elsewere.
Apparatus
During experimental sessions, monkeys sat in a Plexiglas chair
similar to one previously described [25,26] and were restrained in
the seated position by a waist lock (Fig. 1A). The chair was
enclosed in a sound-attenuating isolation chamber (model AC-3,
Industrial Acoustics Co., Bronx, NY). Extraneous sounds were
further masked by continuous white noise. Two-response levers
were mounted in front of the monkeys. When the monkey pressed
either lever with a force of 28 g or more, there was an audible
relay click and a response was recorded. Three stimulus lights
(green, amber and white) were mounted at eye level in front of the
monkeys and used as visual stimuli (Fig. 1A). The middle green
light was illuminated at the beginning of each session and turned
off at the end of the session. The amber and white lights were
located above the active and inactive levers, respectively, and were
illuminated for 2 sec when a ratio was completed on the active or
inactive lever. Teflon tubing connected the monkey’s venous
catheter to a syringe located outside the isolation chamber. The
syringe was driven by a 110-volt a.c. motor, controlled by Med
Associates (St. Albans, VT,USA) automatic programming equip-
ment. Between experimental sessions, monkeys were kept in
individual home cages with food and water freely available. No
food-restriction was used.
Nicotine self-administration
Initially, the monkeys were adapted to sitting in the chambers
during repeated sessions. Then, daily experimental sessions
(Monday through Friday) were started with each monkey. The
green stimulus light was turned on at the beginning of each session
and off at the end of the session. The duration of sessions was
rapidly increased from 15 min to 60 min in less than two weeks.
Initially only one response was required to obtain each 10 mg/kg
intravenous injection of nicotine (one-response fixed-ratio schedule
of reinforcement; FR 1) and after each injection the green light
was turned off for 5 sec (5-sec time-out; TO 5 sec). Then, over
subsequent sessions, the ratio requirement was progressively
increased to a final value of FR10 and the TO duration was
progressively increased to 60 sec. During each 60-min session, each
completion of the ratio on the active lever resulted in illumination of
the amber stimulus lights for two sec paired with an i.v. injection of
10 mg/kg of nicotine, followed by a 60-sec TO, during which the
experimental chamber was dark and lever-press responses had no
programmed consequences. Each completion of the ratio on the
inactive lever resulted in illumination of the white stimulus lights for
two sec but had no other programmed consequences.
Nicotine self administration under the fixed-ratio
schedule
Once the animal learned to quickly decrease its responding during
sessions when saline was substituted for nicotine (extinction), the
dose of nicotine maintaining responding was varied. Doses of 3,
10, 30 and 60 mg/kg of nicotine were studied. Each dose was
evaluated for at least five consecutive sessions and the results of the
last three sessions were usually used for analysis. Saline extinction
sessions were conducted between testing of different nicotine
doses.
Nicotine self administration under the progressive-
ratio schedule
After acquiring nicotine self-administration behavior under the FR
schedule, monkeys were switched to the progressive-ratio schedule.
Under the progressive-ratio schedule of intravenous nicotine
injection, the response requirement increased with each successive
injection. The steps of the exponential progression were adapted
from those used by Roberts and Bennett [56], based on the
following equation: response ratio=[5eX
(0.2xinfusion number)]25,
rounded to the nearest integer. We chose this progression because
it allows a more precise evaluation of the maximum response
requirement that continued to maintain responding (the breaking-
point value), than simply doubling the ratio requirement at each
step. Since the monkeys first learned to self-administer nicotine
under a FR 10 schedule, we used the closest value to 10 in this
progression (i.e. 9) as the first step in the progressive ratio. Thus,
the values of the steps were 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95,
118, 145, 178, 219, 268, 328, 402, 492, 603, 737, 901 and 1102.
Sessions under the progressive-ratio schedule lasted 6 hours or
until 30 min passed without a response. The breaking point was
defined as the step value of the last ratio completed before 30 min
of non-responding or at the end of the 6 hours. Injection dose of
nicotine was then varied. Doses of 0 (saline), 3, 10, 30 and 100 mg/
kg/injection of nicotine were studied under the progressive-ratio
schedule and each dose was studied for at least five consecutive
sessions. Extinction studies were conducted between testing of
different nicotine doses.
Drugs
Nicotine [(-)-nicotine hydrogen tartrate] was purchased from
Sigma Chemical Company (St Louis, Mo., USA). Nicotine was
diluted in saline and the pH of nicotine solution was adjusted to
7.0 with dilute NaOH. Nicotine was administered intravenously
using a solution containing 150 mg/kg nicotine/ml. We used a high
speed of injection (200 msec), previously shown to facilitate
nicotine self-administration and the volume of each injection was
0.2 ml for the 10 mg/kg/injection dose of nicotine. The duration
and volume of injection were changed to vary dose of nicotine. No
priming injections of nicotine were given before sessions and no
non-contingent automatic injections of nicotine were given during
sessions. Doses of nicotine were expressed as mg of free base per kg
body weight.
Data Analysis
Number of lever presses on active and inactive levers, and number
of injections per sessions were recorded. The total nicotine dose
received by the monkeys during the session was also calculated.
The percentage of responses on the nicotine-associated active lever
was calculated for the first five sessions of acquisition under the FR
1 schedule and for five consecutive sessions once stable nicotine
self-administration was acquired. Choice of the active lever was
calculated as a percentage of the number of responses made on the
active lever relative to the total number of responses made on both
levers during the session. Response rates were calculated for each
session by dividing total responses in the presence of the green
light by total time the green light was illuminated. Statistics were
Non-Human Primate and Nicotine
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nicotine dose, time or the lever as factors. LSD-post hoc tests
were used.
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